Search research articles
Contact Us
Filters
Showing results (21-30 of 82) with videos related to
Page
of 9
Sort By:
World Journal of Gastroenterology
|
January 8, 2005
Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer
Bin Pan, Tao Cheng, Ke-Jun Nan, et al.
World Journal of Gastroenterology
|
July 1, 2006
Inhibitory effect of fuzheng yiliuyin in combination with chemotherapeutics on human gastric carcinoma cell strain
Yi Liu, Rui Wang, Gen-Quan Qiu, et al.
World Journal of Gastroenterology
|
October 2, 2007
Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture
Jie Cui, Ke-Jun Nan, Tao Tian, et al.
World Journal of Gastroenterology
|
May 19, 2007
Selenoprotein P mRNA expression in human hepatic tissues
Chun-Li Li, Ke-Jun Nan, Tao Tian, et al.
BMC Gastroenterology
|
May 30, 2012
The balance between two isoforms of LEF-1 regulates colon carcinoma growth
Shu-Hong Wang, Ke-Jun Nan, Yao-Chun Wang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
February 6, 2016
Association between IL-27 2905T/G genotypes and the risk and survival of cervical cancer: a case-control study
Guo-Qing Wang, Wen-Hui Zhao, Xi-Xia Zhao, et al.
Molecular Biology Reports
|
December 17, 2009
Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways
Chuang-xin Lu, Ke-jun Nan, Yan-li Nie, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology
|
December 11, 2008
[Effect of transfection of LKB1 on biological behavior of human lung adenocarcinoma cells]
Xuan Liang, Ke-Jun Nan, Chun-Li Li, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
April 17, 2004
[Therapeutic effects of systemic chemotherapy on advanced pancreatic cancer patients]
Zhao Jing, Ke-Jun Nan, Xiao-Zhan Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 24, 2008
WITHDRAWN: Treatment of combining antiangiogenic therapy and cytotoxic chemotherapy reduce the cancer stem-like cell fraction in hepatocarcinoma xenografts
Shan-Yong Yi, Ke-Jun Nan, Feng Wang, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 82) with videos related to
Sort By:
Page
of 9
World Journal of Gastroenterology
|
January 8, 2005
Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer
Bin Pan, Tao Cheng, Ke-Jun Nan, et al.
World Journal of Gastroenterology
|
July 1, 2006
Inhibitory effect of fuzheng yiliuyin in combination with chemotherapeutics on human gastric carcinoma cell strain
Yi Liu, Rui Wang, Gen-Quan Qiu, et al.
World Journal of Gastroenterology
|
October 2, 2007
Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture
Jie Cui, Ke-Jun Nan, Tao Tian, et al.
World Journal of Gastroenterology
|
May 19, 2007
Selenoprotein P mRNA expression in human hepatic tissues
Chun-Li Li, Ke-Jun Nan, Tao Tian, et al.
BMC Gastroenterology
|
May 30, 2012
The balance between two isoforms of LEF-1 regulates colon carcinoma growth
Shu-Hong Wang, Ke-Jun Nan, Yao-Chun Wang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
February 6, 2016
Association between IL-27 2905T/G genotypes and the risk and survival of cervical cancer: a case-control study
Guo-Qing Wang, Wen-Hui Zhao, Xi-Xia Zhao, et al.
Molecular Biology Reports
|
December 17, 2009
Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways
Chuang-xin Lu, Ke-jun Nan, Yan-li Nie, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology
|
December 11, 2008
[Effect of transfection of LKB1 on biological behavior of human lung adenocarcinoma cells]
Xuan Liang, Ke-Jun Nan, Chun-Li Li, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
April 17, 2004
[Therapeutic effects of systemic chemotherapy on advanced pancreatic cancer patients]
Zhao Jing, Ke-Jun Nan, Xiao-Zhan Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 24, 2008
WITHDRAWN: Treatment of combining antiangiogenic therapy and cytotoxic chemotherapy reduce the cancer stem-like cell fraction in hepatocarcinoma xenografts
Shan-Yong Yi, Ke-Jun Nan, Feng Wang, et al.
Page
of 9